|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:acquiredBy
|
gptkb:Omega_Pharma
|
|
gptkbp:acquisitionYear
|
2015
|
|
gptkbp:CEO
|
gptkb:Patrick_Lockwood-Taylor
|
|
gptkbp:countryOfOrigin
|
gptkb:Ireland
|
|
gptkbp:divested
|
API business (2021)
Rx Pharmaceuticals business (2019)
|
|
gptkbp:dividendPaying
|
yes
|
|
gptkbp:founded
|
1887
|
|
gptkbp:founder
|
gptkb:Luther_Perrigo
|
|
gptkbp:headquarters_location
|
gptkb:Dublin,_Ireland
|
|
gptkbp:headquartersLocation
|
gptkb:Allegan,_Michigan,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Perrigo Company
|
|
gptkbp:industry
|
pharmaceuticals
consumer healthcare
|
|
gptkbp:ISIN
|
IE00BGH1M568
|
|
gptkbp:legalForm
|
gptkb:public_company
|
|
gptkbp:listedOn
|
gptkb:S&P_400
|
|
gptkbp:netIncome
|
$-0.29 billion (2022)
|
|
gptkbp:notableProduct
|
gptkb:Plan_B_One-Step
Compeed
Cold & Flu remedies
store-brand acetaminophen
store-brand ibuprofen
|
|
gptkbp:numberOfEmployees
|
~9,000
|
|
gptkbp:operatesIn
|
gptkb:Australia
gptkb:Europe
gptkb:Israel
gptkb:North_America
|
|
gptkbp:parentCompany
|
none
|
|
gptkbp:previousName
|
gptkb:Perrigo_Company
gptkb:Perrigo_Company_plc
|
|
gptkbp:products
|
infant formula
personal care products
over-the-counter pharmaceuticals
nutritionals
prescription pharmaceuticals
|
|
gptkbp:relocated_headquarters
|
2013
|
|
gptkbp:relocated_headquarters_from
|
gptkb:United_States
|
|
gptkbp:relocated_headquarters_to
|
gptkb:Ireland
|
|
gptkbp:revenue
|
$4.45 billion (2022)
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:PRGO
|
|
gptkbp:subsidiary
|
gptkb:Omega_Pharma
gptkb:PBM_Holdings
HRA Pharma
|
|
gptkbp:type
|
generic drug manufacturer
private label manufacturer
|
|
gptkbp:website
|
https://www.perrigo.com/
|
|
gptkbp:bfsParent
|
gptkb:Omega_Pharma
gptkb:Grupo_Farmaceutico_Somar
|
|
gptkbp:bfsLayer
|
7
|